Videtxorpin 15.9mg/4.8 IU/1.5 mL Somatropin In Pakistan - 03289411929

Videtxorpin 15.9 mg/4.8 IU/1.5 mL Somatropin contains somatropin, a recombinant form of human growth hormone. Somatropin is used as growth-hormone replacement in patients with medically diagnosed growth hormone deficiency and for certain approved growth disorders in children. It works by activating growth-hormone receptors and influencing growth, protein synthesis, and metabolism.

Specifications

• Product: Videtxorpin Somatropin
• Active ingredient: Somatropin
• Strength: 15.9 mg / 4.8 IU
• Volume: 1.5 mL
• Dosage form: Injectable preparation
• Route: Subcutaneous injection
• Therapeutic class: Recombinant human growth hormone
• Use: Growth hormone replacement and selected growth disorders
• Prescription medicine: Yes

The exact formulation and presentation should be verified against the manufacturer's packaging and local product information before listing or dispensing.

Benefits

Somatropin replaces or supplements growth hormone when the body does not produce sufficient amounts. In appropriately diagnosed children, treatment can improve growth velocity and support skeletal growth. In adults with confirmed growth hormone deficiency, replacement therapy can help restore physiological growth-hormone activity and influence body composition and metabolism.

The medicine should not be promoted for bodybuilding, general muscle enhancement, or weight loss without an approved medical indication. Its benefits depend on the underlying diagnosis, age, treatment duration, and individual response.

How to Use

Videtxorpin should be administered only according to a specialist's prescription. Somatropin is generally given by subcutaneous injection, with the injection site rotated among areas such as the abdomen, thigh, buttock, or upper arm. The dose is individualized according to the patient's age, body weight, diagnosis, growth response, and laboratory findings.

Do not change the dose or injection frequency yourself. Patients receiving treatment may require monitoring of growth, blood glucose and other clinical parameters. Somatropin can cause fluid retention, joint or muscle discomfort, headaches, and changes in glucose metabolism; serious complications can also occur in certain patients.